| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,710 | 1,800 | 22.06. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 04.06. | Dividendenbekanntmachungen (04.06.2026) | 13.142 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A-LIVING SMART CITY SERVICES CO LTD CNE100002RY5 0,0688 HKD 0,0075 EUR ADESSO SE DE000A0Z23Q5 - 0,78 EUR AGEAS SA/NV ADR US00844W2089 2... ► Artikel lesen | |
| 29.05. | HAOHAI BIOTEC (06826): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 (UPDATED) | - | HKEx | ||
| 29.05. | HAOHAI BIOTEC (06826): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 1 | HKEx | ||
| SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 29.05. | HAOHAI BIOTEC (06826): RESIGNATION OF AN EXECUTIVE DIRECTOR; CHANGE OF THE CHAIRMAN; AND CHANGE OF COMPOSITION OF BOARD COMMITTEES | 1 | HKEx | ||
| 29.05. | HAOHAI BIOTEC (06826): POLL RESULTS OF AGM, A SHAREHOLDERS' CLASS MEETING AND H SHAREHOLDERS' CLASS MEETING; 2025 PROFIT DISTRIBUTION; CHANGE OF DIRECTORS ... | - | HKEx | ||
| 15.05. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 06.05. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 30.04. | HAOHAI BIOTEC (06826): OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. ANNOUNCEMENT ON THE RECEIPT OF THE "DECISION ... | - | HKEx | ||
| 28.04. | HAOHAI BIOTEC (06826): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 (UPDATED) | 2 | HKEx | ||
| 28.04. | HAOHAI BIOTEC (06826): FORM OF PROXY FOR THE 2026 FIRST H SHAREHOLDERS' CLASS MEETING TO BE HELD ON FRIDAY, 29 MAY 2026 | - | HKEx | ||
| 28.04. | HAOHAI BIOTEC (06826): FORM OF PROXY FOR THE 2025 ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 29 MAY 2026 | - | HKEx | ||
| 28.04. | HAOHAI BIOTEC (06826): NOTICE OF 2026 FIRST H SHAREHOLDERS' CLASS MEETING | - | HKEx | ||
| 28.04. | HAOHAI BIOTEC (06826): NOTICE OF 2025 ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 28.04. | HAOHAI BIOTEC (06826): CIRCULAR OF THE 2025 ANNUAL GENERAL MEETING AND 2026 FIRST H SHAREHOLDERS' CLASS MEETING | - | HKEx | ||
| 27.04. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 24.04. | HAOHAI BIOTEC (06826): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | - | HKEx | ||
| 24.04. | HAOHAI BIOTEC (06826): VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF DEPUTY GENERAL MANAGERS | 1 | HKEx | ||
| 24.04. | HAOHAI BIOTEC (06826): 2026 FIRST QUARTERLY REPORT | 1 | HKEx | ||
| 24.04. | HAOHAI BIOTEC (06826): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION ... | 2 | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VALNEVA | 2,300 | 0,00 % | ALARMSTUFE ROT bei Valneva: Warum erfahrene Anleger heute die Reißleine ziehen - So reagieren erfahrene Anleger jetzt | ||
| AMGEN | 299,20 | +2,47 % | MariTide-Ausblick: Mizuho hebt Amgen-Kursziel auf 303 US-Dollar an | ||
| STRYKER | 266,80 | -1,37 % | Jim Cramer Says Stryker and Its Orthopedic Peers Are Facing a Real Tough Run | ||
| REGENERON PHARMACEUTICALS | 523,70 | -1,08 % | Regeneron Pharmaceuticals, Inc.: Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG) | Cemdisiran could be the first siRNA approved for the treatment of gMG and only therapy to be offered subcutaneously with four times a year dosing FDA accepted NDA under Priority Review with a target... ► Artikel lesen | |
| CSL | 69,20 | -1,37 % | Should I buy CSL and ResMed shares right now? | ||
| BEONE MEDICINES LTD ADR | 236,00 | -0,84 % | BeOne Medicines (ONC): Citizens Sees an Inflection Point in Its Cancer Pipeline | ||
| CANSINO BIOLOGICS | 2,400 | -0,83 % | CanSino Biologics Inc: CanSinoBIO Delivers Q1 Revenue Growth Amid Accelerating International Expansion | HONG KONG, Apr 28, 2026 - (ACN Newswire) - CanSino Biologics Inc. (688185.SH/06185.HK) released its first-quarter 2026 results, reflecting a positive operational momentum. Revenue for the quarter totaled... ► Artikel lesen | |
| BIOMERIEUX | 67,20 | -2,18 % | Dividendenbekanntmachungen (09.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMEREN CORPORATION US0236081024 0,75 USD 0,6501 EUR AMUNDI SA FR0004125920 - 4,25 EUR BECTON DICKINSON AND COMPANY US0758871091 1... ► Artikel lesen | |
| SINO BIOPHARM | 0,518 | +2,35 % | SBP GROUP (01177): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | ||
| ZAI LAB LTD ADR | 16,000 | +1,27 % | ZAI LAB (09688): NEXT DAY DISCLOSURE RETURN | ||
| CSTONE PHARMACEUTICALS | 0,504 | +4,32 % | CSTONE PHARMA-B (02616): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE CIRCULAR OF THE ANNUAL GENERAL MEETING | ||
| CASI PHARMACEUTICALS | 0,214 | -4,13 % | Riverty Establishes Bank in Luxembourg | Fintech granted EU CRR banking licence after a 10-month application processRiverty transforms its Payment and Credit business from a PSD2 payment institution into a fully licensed bankBank... ► Artikel lesen | |
| 3SBIO | 1,839 | +2,34 % | 3SBIO (01530): NEXT DAY DISCLOSURE RETURN | ||
| APOGEE THERAPEUTICS | 132,64 | +46,76 % | Apogee Therapeutics: Hier dürfte zum US-Handelsstart heute die Post abgehen! | AbbVie steht laut einem Bericht kurz vor der Übernahme von Apogee Therapeutics für rund 10,9 Milliarden US-Dollar in bar. Der mögliche Aufschlag liegt bei etwa 60 Prozent. Weil die US-Börsen am Freitag... ► Artikel lesen | |
| KYMERA THERAPEUTICS | 99,02 | +9,50 % | Truist reiterates Kymera stock Buy rating after AbbVie deal |